I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Gedik, HATİCE; Hoefnagel, Cornelis; Bais, Evert; Olmos, Renato

doi:10.1007/s00259-007-0652-6

I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Gedik G. K., Hoefnagel C. A., Bais E., Olmos R. A. V.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.35, no.4, pp.725-733, 2008 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 35 Issue: 4
Publication Date: 2008
Doi Number: 10.1007/s00259-007-0652-6
Journal Name: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.725-733
Hacettepe University Affiliated: Yes

Abstract

Purpose (131)Iodine metaiodobenzylguanidine (I-131-MIBG) is a radiopharmaceutical used for scintigraphic localisation of phaeochromocytomas and paragangliomas. The experience with its therapeutic use is limited. We report our experience for the treatment of malignant phaeochromocytoma and paraganglioma.